SUPPLEMENTARY MATERIAL Effect of a topical formulation containing Calophyllum brasiliense Camb. extract on cutaneous wound healing in rats T.V.A. Lordania, M.A. Brenzanb, L.E.R. Corteza, C.R.F. Lordanic, P.A. Hondab, M. V.C. Lonardonid and D.A.G. Corteza,b* a Programa de Pós-graduação em Promoção da Saúde, Centro Universitário de Maringá, CESUMAR, Av. Guerdner 1610, Jd. Aclimação, 87050-900 Maringá, PR, Brasil. b Pós-graduação em Ciências Farmacêuticas, Departamento de Farmácia e Farmacologia, Universidade Estadual de Maringá, Av. Colombo 5790, 87020-900 Maringá, PR, Brasil. c Departamento de Nutrição, Faculdade Assis Gurgacz, Av. das Torres 500, 85806-095 Cascavel, PR, Brasil. d Pós-Graduação em Biociências e Fisiopatologia, Universidade Estadual de Maringá, Av. Colombo 5790, 87020-900 Maringá, PR, Brasil. * Corresponding author. Email: dagcortez@uem.br Abstract This study evaluated the wound healing effects of topical application of an emulsion containing the HPLC standardized extract from C. brasiliense Cambess (Clusiaceae) leaves in rats. The macroscopic analysis demonstrated that the wounds treated with the C. brasiliense emulsion healed earlier than the wounds treated with emulsion base and Dersani®. The percentage of wound healing in the group treated with the C. brasiliense emulsion was significantly higher than in the other groups at 7 and 14 days. On day 14, the animals treated with the C. brasiliense emulsion exhibited a 90.67% reduction of the wound areas. The histological evaluation revealed that on day 21, the group treated with the C. brasiliense emulsion exhibited a significant increase in fibroblasts compared with the other groups. Thus, the C. brasiliense emulsion had healing properties in the topical treatment of wounds and accelerated the healing process. Keywords: wound healing, topical treatment, Calophyllum brasiliense, crude extract, rat 1. Experimental Plant material Calophyllum brasiliense Cambess (Clusiaceae) leaves were collected in Cardoso Island, São Paulo state, Brazil, in December 2010. A voucher specimen (SP 363818) was identified by Prof. Dra. Maria Claudia M. Young and deposited and authenticated at the Herbarium of the Botany Institute of São Paulo, São Paulo, Brazil. The leaves were dried at 35°C in a circulating air oven and triturated in a knife mill (Usi-ram®). Plant extraction The powdered leaves (800 g) were extracted by exhaustive maceration in ethanol:water (9:1) at room temperature, filtered, and concentrated under vacuum at 40°C to obtain an aqueous extract and dark-green residue. The dark-green residue was dissolved with dichloromethane, and the solvent was then completely evaporated at room temperature to yield a dichloromethane extract (25.0 g) (Brenzan et al. 2007; 2008a, 2008b; Honda et al. 2010; Honda et al. 2011). The bioactive (-) mammea A/BB coumarin was quantified in the crude dichloromethane extract by high-performance liquid chromatography (HPLC) according to the methodology described by Pires et al. (2014). High-Performance Liquid Chromatography (HPLC) analysis The extract from C. brasiliense leaves and the coumarin (-) mammea A/BB were analyzed by HPLC-UV using HPLC-UV grade solvents and ultrapure water (Milli-Q system, Millipore, Bedford, MA, USA) and a Waters 1525 liquid chromatograph equipped with a binary pump (LC-10 AD), automatic injection valve 135 (Rheodyne) with a 20 μL loop, CTO-10AVP thermostat-controlled oven compartment (Shimadzu) and a 2489 UV/visible detector (Waters) controlled by Breeze 2 software (OmniSolv EM Science, Gibbstown, NJ, USA). A MetaSil ODS column (5 μm; 150 × 4.6 mm) maintained at 25ºC was used in the chromatographic analysis. The separation was conducted in a gradient system, using a mixture of acetonitrile and ultrapure water 55:45 v/v to 80:20 (0-10 min), 80:20 v/v to 100% (10-20 min), 100% acetonitrile (20-25 min) and 55:45 v/v (26-30 min) as the mobile phase, at a flow rate of 0.6 mL/min. Detection was performed at 336 nm and the running time was 30 min. The sample injection volume was 20 μL. The extract from C. brasilense leaves (3 mg/mL) and compound (-) mammea A/BB (1 mg/mL) were dissolved in methanol, filtered through a membrane filter (Millipore, Brazil). Compound (-) mammea A/BB was quantified in the extract from C. brasilense leaves by HPLC-UV using as the standard the (-) mammea A/BB previously isolated and identified from the C. brasiliense leaves (Brenzan et al. 2008a, 2008b, 2012; Tiuman et al. 2013). The calibration curve was prepared using (-) mammea A/BB standard at concentrations ranging from 15.63 to 250 µg/mL in methanol. Three determinations were carried out for each sample. For the determination of the contents of (-) mammea A/BB in the extract, the regression equation y = 61589x + 52298 was used. The statistical analyses of the data were performed using Statistica 8.0 software (Statsoft Inc, Tulsa, OK, USA) (Pires et al. 2014). Preparation of the topical formulation containing the extract from C. brasiliense leaves A non-ionic emulsion containing the extract from C. brasiliense leaves at a concentration of 10% (w/w) was prepared according to described in the patent for this topical formulation (Honda et al. 2010, 2011). To prepare the emulsion was used the HPLC standardized extract that contained 28.04 ± 0.9 µg of (-) mammea A/BB per mg of extract. The emulsion formulation was prepared by adding an aqueous phase in oil phase under constant agitation. To prepare the emulsion formulation, we used 6 % cetostearyl alcohol (w/w), 5 % octyldodecanol (w/w), 7 % mineral oil (w/w), 12 % ethoxylated alcohol stearyl (w/w), 18 % glycerin monoestarate (w/w), 10 % propylene glycol (w/w), and purified water in sufficient quantity. The standardized extract from C. brasiliense leaves was weighed and added to the emulsion in small amounts until a final concentration of 10% (w/w) was reached under constant stirring. The pH of the formulation was 5.5. The formulations, with and without the addition of the extract, were termed as the emulsion of the C. brasiliense extract and emulsion base control, respectively. The formulations were prepared a few days before beginning the experiments, stored in closed flasks, and protected from light and heat. Experimental animals Forty-five adult male albino Wistar rats (Rattus norvegicus), weighing 200 ± 5 g, were obtained from the Animal Facility of the Assis Gurgacz Faculty. The animals were randomly divided into three groups (n = 15 per group). These groups were further randomly divided into three subgroups according to the observation period (7, 14 and 21 days after surgery; n = 5 per subgroup). The animals were individually housed in polyethylene cages under controlled environmental conditions (23 ± 2C, 50-70% relative humidity, 12 h/12 h light/dark cycle) and were provided water and food ad libitum. The animals were allowed a 7 day acclimation period before the start of the experiments. The experimental protocol was approved by the Animal Ethics Committee of the Assis Gurgacz Faculty (protocol no. 032/2012). Experimentally induced excision wounds An excision wound was inflicted in each rat according to the methods described by Panchatcharam et al. (2006) with modifications. Prior to skin wound induction, the animals were intraperitoneally anesthetized with 10 mg/kg xylazine and 75 mg/kg ketamine hydrochloride (Fiocruz, 2005). The skin was manually depilated using a stainless steel blade and disinfected with 70% alcohol. To demarcate the surgical incision area, a transparent 2 2 cm sheet was used with a total area of 4 cm2. The boundaries were demarcated with black ink on the skin. Prior to performing the surgical incision, an antiseptic alcoholic solution of 2% chlorhexidine was applied. The surgical incisions were made on the back, close to the cervical area of each animal. The resection of the skin was performed using a scalpel blade in the demarcated area. Afterward, the incision was deepened to expose the dorsal muscle fascia (Figure S1). Hemostasis was performed using sterile compression gauze. Wound areas were measured immediately using a digital caliper (Pantec®Brazil). The wounds of the animals were topically treated according to the experimental groups. Topical wound treatment Soon after making the excision wounds, the animals were individually housed in cages and received their respective treatments. The cutaneous wounds were topically treated according to the experimental groups. Group A: The wounds were treated with 0.2 ml of the non-ionic emulsion containing the extract of C. brasiliense at 10%, equivalent to 0.32 g of the C. brasiliense extract. Group B: The wounds in the emulsion base control group were treated with 0.2 ml of the non-ionic emulsion base without the addition of the extract, equivalent to 0.3 g of the excipients of the base. Group C: The wounds in the Dersani ® group were treated with 0.2 ml of Dersani®, sufficient to cover the entire wound. Dersani® is indicated for any type of cutaneous lesion as a bactericide during the different phases of the healing process (Maldebaum et al. 2003). The treatment was repeated daily. The animals did not receive postoperative dressings and continued to receive this treatment until the date set for the measurements (7, 14, and 21 days after the first treatment). The experimental protocol was approved by the Animal Ethics Committee of the Assis Gurgacz Faculty (protocol no. 032/2012). Estimation of wound healing (wound closure) Measurements were performed in all of the animals on day 0 (i.e., the day of surgery) and 7, 14 and 21 days after the first treatment. For this, the animals were intraperitoneally anesthetized with 40 mg/kg thiopental and immobilized. The evaluation of the healing process was performed using a digital caliper (Pantec®,Brazil) by measuring the length and width of the wound, which were measured as the linear distance between the edges of the lesion (Garros et al. 2006). The length refers to the direction of the wound going from the head to tail of the animal. The width was measured from side to side. After the measurements, the square area of the lesion was calculated. During the measurements, the wounds were photographed using a Sony Cyber shot DSCW320 camera to macroscopically analyze wound healing. The wound closure rate is expressed as a percentage of the wound area compared with postoperative day 0 as described previously (Zahra et al. 2011; Hajiaghaalipour et al. 2013) i.e., the change in wound size is expressed as a percentage of the original wound size. Histological evaluation of the wounds For histological evaluation, a fragment of the wound was removed in all of the groups (a 0.5 cm edge on each side of the injury). The skin fragments were immediately fixed in 10% buffered formalin, dehydrated and embedded in paraffin. Afterward, the animals were sacrificed by decapitation. Tissue blocks were cut at 4 μm thickness using a microtome (Leica Microsystems, Germany), stained with hematoxylin-eosin and Masson’s trichome, and examined using an Olympus BX60 light microscope. Three slides were prepared per animal. The histological analysis evaluated acute inflammation, chronic inflammation, wound healing, fibroblast proliferation, collagen deposition and neovascularization. The intensity of these histological parameters was classified using a 0-4 numerical scale as described previously (Hunt & Mueller 1994; Hajiaghaalipour et al. 2013): 0 (absence), 1 (occasional presence), 2 (light scattering), 3 (abundant), and 4 (confluence of cells or fibers). Statistical analysis The experimental results are expressed as the mean ± standard deviation of five animals in each group. The statistical analysis was performed using Statistica® 7.0 software. Analysis of variance (ANOVA) was used for comparisons between groups. Tukey’s test was used for comparisons between means. The intergroup analysis was performed using the nonparametric Kruskal-Wallis test. Values of p < 0.05 were considered statistically significant. Table S1. Effect of an emulsion containing the extract from C. brasiliense leaves on excision wound healing in rats 7, 14 and 21days, after surgery. Percentage of wound healing (mean ±SD) on days after surgery Treatment groups Day 7 Day 14 Day 21 26.67 ± 2.08a,b 90.67 ± 4.71a,b 92.0 ± 4.72 Emulsion base control 9.64 ± 4.73 66.33 ± 2.08 79.8 ± 4.73 Dersani® 8.25 ± 7.18 62.4 ± 6.7 82.67 ± 3.51 Emulsion of C. brasiliense extract Mean values (n=5) followed by different letters (a and b) in a column are significantly difference (p <0.05). a Different from the control group, b Different from the Dersani® group. Table S2. The median histopathologic scores of wound healing were determined in the emulsion of C. brasiliense extract, emulsion base control and Dersani® groups on day 21 by using a 0 to 4 numerical scale. The scores were 0 for absence, 1 for occasional presence, 2 for light scattering, 3 for abundance, and 4 for confluence of cells or fibres. Acute Chronic Fibroblast inflammation inflammation proliferation Emulsion of C. brasiliense extract 1.0 ± 0.0a 1.6 ± 0.55a 3.2 ± 0.45a 1.0 ± 0.0a 3.2 ± 0.45a Emulsion base control 1.0 ± 0.0a 0.6 ± 0.55b 1.0 ± 0.0b 0.82 ± 0.55a 2.4 ± 0.55a Dersani® 0.8 ± 0.45a 1.6 ± 0.55a 1.4 ± 0.55b 1.8 ± 0.44b 3.0 ± 0.0a Groups Neovascularization Epithelization Data expressed as mean ± standard deviation (n=5). Different letters (a and b) in a column indicate statistically significant difference (p < 0.05). are Figure S1. Excision skin wound (4 cm2) on the day of surgery before treatment. Where can see the exposure of the dorsal muscle fascia. Figure S2. Chromatograms of the standard (-) mammea A/BB (1) (Rt = 21.8 min) (A) and extract from C. brasiliense leaves (B). Chromatographic conditions: MetaSil ODS column; mobile phase: acetonitrile-water 55:45 v/v to 80:20 (0-10 min), 80:20 v/v to 100% (10-20 min), 100% acetonitrile (20-25 min) and 55:45 v/v (26-30 min); flow rate 0.6 mL/min; temperature 25°C; detection: 336 nm. (1) (-) mammea A/BB Figure S3. Macroscopic appearance of the wounds 7, 14 and 21 days after surgery. (A-C) Group A: Topical treatment with emulsion of the C. brasiliense extract. (D-F) Group B: Treatment with emulsion base only. (G-I) Group C: Treatment with Dersani®. Figure S4. Histology of wound area stained with hematoxylin and eosin on day 21 after surgery. A) Group A: Topical treatment with emulsion of the C. brasiliense extract. (B) Group C: Treatment with Dersani®. (C) Group B: Treatment with emulsion base only. The arrows indicated the fibroblasts. Magnification: 40 x. References Brenzan MA, Nakamura CV, Dias-Filho BP, Ueda-Nakamura T, Young MCM, Cortez DAG. 2007. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res. 101:715-22. Brenzan MA, Ferreira ICP, Lonardoni MVC, Honda PA, Rodriguez- Filho E, Nakamura CV, Cortez, DAG. 2008a. Activity of extracts and coumarins from leaves of Calophyllum brasiliense Camb. on Leishmania braziliensis. Pharm Biol. 46:1-7. Brenzan MA, Nakamura CV, Dias-Filho BP, Ueda-Nakamura T, Young MCM, Côrrea AG, Alvim-Júnior J, Santos AO, Cortez DAG. 2008b. Structure–activity relationship of (−) mammea A/BB derivatives against Leishmania amazonensis. Biomed Pharmacother. 62(6):651–658. Brenzan MA, Santos AO, Nakamura CV, Dias-Filho BP, Ueda-Nakamura T, Young MCM, Côrrea AG, Alvim-Júnior J, Morgado-Díaz JA, Cortez DAG. 2012. Effects of (−) mammea A/BB isolated from Calophyllum brasiliense leaves and derivatives on mitochondrial membrane of Leishmania amazonensis. Phytomedicine. 19:223–230. Fundação Oswaldo Cruz (Fiocruz). 2005. Curso de Manipulação de Animais de Laboratório. Centro de Pesquisas Gonçalo Luiz. Ministério da Saúde. Bahia. Garros IC, Campos ACL, Tâmbara EM, Tenório SB, Torres OJM, Agulham MA, Araújo ACF, Sains-Isolan PMB, Oliveira EM, Arruda ECM. 2006. Extrato de Passiflora edulisna cicatrização de feridas cutâneas abertas em ratos: estudo morfológico e histológico. Acta Cir Bras. 21(3):55-65. Hajiaghaalipour F, Kanthimathi MS, Abdulla MA, Sanusi J. 2013. The effect of Camellia sinensis on wound healing potential in an animal model. Evid Bas Complement Alter Med. 2013:1-7. Honda PA, Ferreira ICP, Cortez DAG, Amado CAB, Silveira TGV, Brenzan MA, Lonardoni MVC. 2010. Efficacy of components from leaves of Calophyllum brasiliense against Leishmania (Leishmania) amazonensis. Phytomedicine. 17:333–38. Honda PA, Brenzan MA. Ferreira ICP, Lonardoni MVC, Nakamura CV, Dias-Filho BP, Cortez DAG. 2011. Topical formulation used for treating leishmaniasis (cutaneous leishmaniasis with cutaneous lesions) in animal and humans, contains hexane or dichloromethane extract of Calophyllum brasiliense with vehicles, diluents and additives Brazil patent BR200904042A2. Hunt T, Mueller R. 1994. Wound healing: Current Surgical Diagnosis and Treatment. 10th ed., Appleton and Lange: Paramus, NJ, USA. p. 80–93. Mandelbaum SH, Di Santis EP, Mandelbaum MHS. 2003. Cicatrização, conceitos atuais e recursos auxiliares – Parte I. An Bras Dermatol. 78(5):525-542. Panchatcharam M, Miriyala S, Gayathri VS, Suguna L. 2006. Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cel Biochem. 290:87–96. Pires CTA, Brenzan MA, Scodro RBL, Cortez DAG, Lopes LDG, Siqueira VLD, Cardoso RF. 2014. Anti-Mycobacterium tuberculosis activity and cytotoxicity of Calophyllum brasiliense Cambess (Clusiaceae). Mem Inst Oswaldo Cruz. 109(3):324-329. Tiuman TS, Brenzan MA, Ueda-Nakamura T, Dias-Filho BP, Cortez DAG, Nakamura CV. 2012. Intramuscular and topical treatment of cutaneous leishmaniasis lesions in mice infected with Leishmania amazonensis using coumarin (−) mammea A/BB. Phytomedicine. 19(3):1196-1199. Zahra AA, Kadir FA, Mahmood AA, Alhadi AA, Suzy SM, Sabri SZ, Latif II, Ketuly KA. 2011. Acute toxicity study and wound healing potential of Gynura procumbens leaf extract in rats. J Med Plants Res. 5(12):2551–2558.